AUSTCO HEALTHCARE LIMITED (AHC)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

AHC

AHC - AUSTCO HEALTHCARE LIMITED

FNArena Sector : NONE
Year End: June
GICS Industry Group : Real Estate
Debt/EBITDA: 0.3
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.42

28 Nov
2025

0.010

OPEN

$0.42

2.44%

HIGH

$0.42

12,881

LOW

$0.42

TARGET
$0.55 31.0% upside
FNARENA'S MARKET CONSENSUS FORECASTS
AHC: 1
Title FY24
Actual		 FY25
Actual		 FY26
Forecast		 FY27
Forecast
EPS (cps) xxx 1.6 2.5 xxx
DPS (cps) xxx 0.0 0.0 xxx
EPS Growth xxx - 30.0% 53.4% xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 16.8 xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A N/A xxx

Dividend yield today if purchased 3 years ago: N/A

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 N/A

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 10/11 - (franking Ex-Di

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic xxxxxxxxxxxxxxx1.6
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx81.4 M
Book Value Per Share xxxxxxxxxxxxxxx14.2
Net Operating Cash Flow xxxxxxxxxxxxxxx13.4 M
Net Profit Margin xxxxxxxxxxxxxxx7.29 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed xxxxxxxxxxxxxxx12.35 %
Return on Invested Capital xxxxxxxxxxxxxxx11.86 %
Return on Assets xxxxxxxxxxxxxxx7.42 %
Return on Equity xxxxxxxxxxxxxxx12.35 %
Return on Total Capital xxxxxxxxxxxxxxx19.75 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx10.7 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt xxxxxxxxxxxxxxx1 M
Long Term Debt xxxxxxxxxxxxxxx3 M
Total Debt xxxxxxxxxxxxxxx4 M
Goodwill - Gross xxxxxxxxxxxxxxx21 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx14 M
Price To Book Value xxxxxxxxxxxxxxx2.04

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex xxxxxxxxxxxxxxx4.7 M
Capex % of Sales xxxxxxxxxxxxxxx5.82 %
Cost of Goods Sold xxxxxxxxxxxxxxx63 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx8 M
Research & Development xxxxxxxxxxxxxxx3 M
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Bell Potter

30/10/2025

1

Buy

$0.55

30.95%

Bell Potter assesses Austco Healthcare delivered a strong first quarter FY26 revenue and earnings (EBITDA) margin performance, driven by both organic and acquired growth.

Revenue rose around 51% year-on-year to $23.2m, while earnings (EBITDA) reached around $4.2m for a margin of about 18.1%, up from 16% a year earlier.

The analysts attribute the circa 210bps margin improvement to operating leverage from recent systems integrator acquisitions that enhanced efficiency and supplier pricing.

Organic growth remains in double digits, highlights the broker, supported by rising demand for Austco’s nurse call systems and a $54.6m order book.

Bell Potter retains a Buy rating and a 55c target price.

FORECAST
Bell Potter forecasts a full year FY26 dividend of 0.00 cents and EPS of 2.50 cents.
Bell Potter forecasts a full year FY27 dividend of 0.00 cents and EPS of 2.90 cents.
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
Access Extra Coverage Research History >

AHC STOCK CHART

FNArena News on AHC

No Records